Journal
JOURNAL OF ORAL SCIENCE
Volume 63, Issue 1, Pages 22-26Publisher
NIHON UNIV, SCHOOL DENTISTRY
DOI: 10.2334/josnusd.19-0504
Keywords
biological markers; hyposalivation; metabolomics; oral diagnosis; proton magnetic resonance spectroscopy
Funding
- Finnish Funding Agency's for Technology and Innovation (Tekes) Oraldent project [2186/31/2010]
- Finnish Funding Agency's for Technology and Innovation (Tekes) Oral Cancer project [52/31/2014]
- Finnish Dental Association Apollonia
Ask authors/readers for more resources
The study investigated the inter- and intra-individual variation in levels and outputs of salivary metabolites in pSS patients. Results showed significant elevation of certain metabolites in patients with large inter-individual variation, indicating their potential use as new biological markers for monitoring treatment response.
Purpose: To investigate inter- and intra-individual variation in the levels and outputs (concentration multiplied by salivary flow rate) of salivary metabolites in patients with primary Sjogren's syndrome (pSS). Methods: A total of 56 samples of stimulated saliva were collected from 14 female pSS patients during four laboratory visits within 20 weeks and analyzed using proton nuclear magnetic resonance spectroscopy. Single saliva samples from each of 15 controls were also analyzed. Results: Among 21 quantified metabolites, choline was significantly elevated in the pSS patients at each time point (P <= 0.015), taurine at the last three time points (P <= 0.013), alanine at the last two time points (P <= 0.007) and glycine at the last time point (P = 0.005). Inter-individual variation in metabolite concentrations was generally larger among the patients than among the controls, and significantly large variations were observed for glycine (P <= 0.007, all time points), choline (P <= 0.033, three last time points) and alanine (P = 0.028, baseline). Metabolite output analysis showed that choline had the lowest intra-patient variation. Conclusion: In spite of considerable intra- and inter-individual variation. levels and outputs of specific metabolites in patients with pSS differ from those in controls, and may be potentially applicable as new biological markers for monitoring of the response to treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available